The Australian share market is experiencing cautious optimism, with potential shifts hinging on key decisions from the Reserve Bank and Fair Work. In this context, penny stocks—often associated with smaller or emerging companies—remain a compelling area for investors seeking growth opportunities. Despite being an older term, penny stocks continue to attract attention for their potential to offer significant returns when backed by strong financial health.
Top 10 Penny Stocks In Australia
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| Shaver Shop Group (ASX:SSG) |
A$1.295 |
A$169.66M |
★★★★★★ |
| West African Resources (ASX:WAF) |
A$3.20 |
A$3.66B |
★★★★★★ |
| LaserBond (ASX:LBL) |
A$0.53 |
A$62.65M |
★★★★★★ |
| Regal Partners (ASX:RPL) |
A$2.59 |
A$948.99M |
★★★★★★ |
| Praemium (ASX:PPS) |
A$0.645 |
A$314.42M |
★★★★★★ |
| Australian Ethical Investment (ASX:AEF) |
A$4.53 |
A$515.65M |
★★★★★★ |
| EDU Holdings (ASX:EDU) |
A$0.705 |
A$88.09M |
★★★★★★ |
| Integrated Research (ASX:IRI) |
A$0.305 |
A$55.08M |
★★★★★★ |
| Kingsgate Consolidated (ASX:KCN) |
A$4.40 |
A$1.18B |
★★★★★★ |
| CTI Logistics (ASX:CLX) |
A$1.80 |
A$141.29M |
★★★★☆☆ |
Click here to see the full list of 398 stocks from our ASX Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Predictive Discovery
Simply Wall St Financial Health Rating:★★★★☆☆
Overview:Predictive Discovery Limited is engaged in the exploration, identification, and development of economic mineral reserves in West Africa, with a market cap of A$1.96 billion.
Operations:The company has not reported any revenue segments.
Market Cap:A$1.96B
Predictive Discovery Limited, with a market cap of A$1.96 billion, is pre-revenue and unprofitable, with losses increasing at 18.8% annually over the past five years. Despite this, it has no debt and its short-term assets (A$44.5M) exceed liabilities (A$6.9M), though it has less than a year of cash runway based on current free cash flow. The management team is experienced, but significant insider selling occurred recently. Notably, the company was added to the S&P/ASX 200 Index in March 2026, reflecting its growing prominence despite financial challenges. Earnings are forecasted to grow significantly at 65.13% per year.
-
Jump into the full analysis health report here for a deeper understanding of Predictive Discovery.
-
Evaluate Predictive Discovery's prospects by accessing our earnings growth report.
Regal Partners
Simply Wall St Financial Health Rating:★★★★★★
Overview:Regal Partners Limited is a privately owned hedge fund sponsor with a market capitalization of A$948.99 million.
Operations:The company generates revenue of A$377.39 million from its investment management services segment.
Market Cap:A$948.99M
Regal Partners Limited, with a market cap of A$948.99 million, demonstrates strong financial health with short-term assets (A$374.6M) surpassing both short-term (A$128.1M) and long-term liabilities (A$36.0M). The company reported significant earnings growth of 97.1% over the past year, driven by revenue of A$377.39 million and net income of A$130.55 million for 2025, indicating high-quality earnings despite a low return on equity (13.9%). Recent executive changes include Ilana Stringer as CFO, potentially impacting strategic direction amidst stable weekly volatility and an ongoing share repurchase program aimed at maximizing shareholder returns.
-
Click to explore a detailed breakdown of our findings in Regal Partners' financial health report.
-
Explore Regal Partners' analyst forecasts in our growth report.
Sigma Healthcare
Simply Wall St Financial Health Rating:★★★★★★
Overview:Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale distributor to community pharmacies primarily in Australia, with a market cap of A$30.48 billion.
Operations:The company's revenue is primarily derived from its Healthcare segment, which generated A$9.55 billion.
Market Cap:A$30.48B
Sigma Healthcare Limited, with a market cap of A$30.48 billion, shows a robust financial position as its short-term assets (A$3.3 billion) exceed both short-term (A$2 billion) and long-term liabilities (A$1.9 billion). The company's debt is well covered by operating cash flow at 61.3%, and interest payments are adequately managed with EBIT coverage of 13.2 times. Despite having high-quality earnings and reduced debt levels over five years, Sigma's return on equity remains low at 12.2%. Recent earnings for the half-year ending December 2025 showed significant sales growth to A$5.51 billion from A$1.96 billion year-on-year, while net income increased to A$379.82 million from A$309.93 million the previous year.
Key Takeaways
-
Unlock more gems! Our ASX Penny Stocks screener has unearthed 395 more companies for you to explore.Click here to unveil our expertly curated list of 398 ASX Penny Stocks .
-
Interested In Other Possibilities? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:PDI ASX:RPL and ASX:SIG.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
